XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 160 filers reported holding XENON PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,025,200 | -11.3% | 1,845,000 | 0.0% | 7.37% | -7.7% |
| Q2 2023 | $71,032,500 | +7.6% | 1,845,000 | 0.0% | 7.98% | -20.6% |
| Q1 2023 | $66,032,550 | +100837.9% | 1,845,000 | +11.2% | 10.05% | +2.0% |
| Q4 2022 | $65,419 | -99.9% | 1,659,111 | +4.0% | 9.86% | +6.5% |
| Q3 2022 | $57,577,000 | +18.7% | 1,594,932 | 0.0% | 9.26% | -9.7% |
| Q2 2022 | $48,518,000 | +32.0% | 1,594,932 | +32.6% | 10.26% | +24.9% |
| Q1 2022 | $36,764,000 | +8.0% | 1,202,613 | +10.3% | 8.21% | +4.1% |
| Q4 2021 | $34,056,000 | +284.6% | 1,090,126 | +88.1% | 7.89% | +237.9% |
| Q3 2021 | $8,854,000 | +45.7% | 579,432 | +77.6% | 2.33% | +10.3% |
| Q2 2021 | $6,076,000 | +12.6% | 326,336 | +8.3% | 2.12% | -1.5% |
| Q1 2021 | $5,395,000 | -24.9% | 301,392 | -35.5% | 2.15% | -45.0% |
| Q4 2020 | $7,188,000 | – | 467,368 | – | 3.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |